Clinical Trials in Nashville

Showing 16921-16940 of 20,298 trials

A Open Label Extension Study for Subjects That Complete Study MP-101-CL-001

NCT02246816

MP-101 will be evaluated in this study to see if it is safe and tolerable.

Short Bowel SyndromeShort Gut SyndromeSBS+1 more

Marathon Pharmaceuticals, LLCStarted Feb 2015

Chicago, Illinois, United States • Indianapolis, Indiana, United States • Cleveland, Ohio, United States +2 more locations

WITHDRAWNPhase 3< 1 mile

A Phase III Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Investigational Product MP-101 in Subjects With Short Bowel Syndrome Who Have Had an Inadequate Response to Anti-Diarrheals

NCT02242656

MP-101 will be evaluated in this study to see if it is safe, tolerable, and can help people with Short Bowel Syndrome. This study will also find out if taking MP-101 can improve the symptoms of Short Bowel Syndrome and reduce the number of times subjects experience bowel movements.

Short Bowel SyndromeShort Gut SyndromeSBS+2 more

Marathon Pharmaceuticals, LLCStarted Dec 2014

Chicago, Illinois, United States • Indianapolis, Indiana, United States • Cleveland, Ohio, United States +2 more locations

A Open Label Extension Study for Subjects That Complete Study MP-101-CL-001

A Phase III Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Investigational Product MP-101 in Subjects With Short Bowel Syndrome Who Have Had an Inadequate Response to Anti-Diarrheals

Find Trials by Condition in Nashville

Peds Sanofi H1N1 Influenza Vaccine Administered at Two Dose Levels

A Study of NK012 in Patients With Advanced, Metastatic Triple Negative Breast Cancer

hu14.18-Interleukin-2 Fusion Protein in Treating Young Patients With Recurrent or Refractory Neuroblastoma

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Multiple Dose Study Of PF-05231023 In Adult Subjects Who Have Poor Lipid Control With And Without Type 2 Diabetes Mellitus

A Study of TMC435 in Combination With PSI-7977 (GS7977) in Chronic Hepatitis C Genotype 1-Infected Prior Null Responders To Peginterferon/Ribavirin Therapy or HCV Treatment-Naive Patients

Safety Study of IV Peramivir in Hospitalized Subjects With Confirmed or Suspected Influenza

Trial of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in the Acute Treatment of Adults With Schizophrenia

Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis

Ligation of the Intersphincteric Fistula Tract (LIFT) + Biodesign for Anal Fistula

Study of Physiological and High Dose Estradiol in the Treatment of Hormone Receptor Positive Metastatic Breast Cancer

Safety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Healthy Adults

Atazanavir/Ritonavir, Once Daily + Raltegravir, Twice Daily, Switch Study in HIV-1-Infected Patients

Comparison of the Safety of Flublok® Versus Licensed IIV in Healthy, Medically Stable Adults ≥ 50 Years of Age

Study With TMX-101 in Patients With Carcinoma In Situ (CIS) Bladder Cancer

Allo BMT Using Matched Related/Unrelated Donors With FluBu and HiCY

A Dose-Escalation to Rash Study of Tarceva (Erlotinib) Plus Gemcitabine in Patients With Metastatic Pancreatic Cancer

Safety Extension Study to Evaluate the Biodegradation of the Brimonidine Tartrate Posterior Segment Drug Delivery System